Work

Screening statins for possible carcinogenic risk: up to 9 years of follow‐up of 361 859 recipients

Year: 2007

Type: article

Study design: Observational Study

Source: Pharmacoepidemiology and Drug Safety

DOI: 10.1002/pds.1507

Authors: Gary D. Friedman, E. Dawn Flick, Natalia Udaltsova, James Chan Pharm D, Charles P. Quesenberry, Laurel A. Habel

Institutions: Kaiser Permanente, Kaiser Permanente Oakland Medical Center, Stanford Medicine, Stanford University

Language: English

Topic: Cancer, Lipids, and Metabolism

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: Pharmaceuticals and Cancer

OpenAlex ID: W2019411105

FWCI: 4.939

Cites: 34

Cited by: 220

Related to: 10